International registry on thoracic cancer patients with COVID-19 (Thoracic cancERs international coVid 19 cOLlaboraTion) TERAVOLT
This is a longitudinal multi-centre study on thoracic cancer patients (any age, sex, histology, stage, in active treatment as well as in clinical follow-up) which, experienced COVID-19. Information on clinical features, clinical course, management and outcomes will be collected for both, thoracic cancers and COVID-19 infection. It is proposed to develop a tailored risk assessment strategy for thoracic cancer patients and develop treatment recommendations for thoracic cancer patients.
Click Here for more information
Principle Investigator: Matthew Puc, M.D.
Contacts for Participation in Clinical Trials:
Virtua Samson Cancer Center
Theresa Carducci, MSN, RN, BA, CCRP
Protocol Coordinator, Cancer Registry & Research
Karen Goldsmith, BSN, RN
Maria Jenkins, CCRP
Clinical Research Coordinator